创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

中药活性成分共晶的开发与应用进展

Progress in the Development and Application of Pharmaceutical Cocrystals from Traditional Chinese Medicine

  • 摘要: 中药活性成分广泛存在水溶性低、稳定性差等问题,这在一定程度上限制了其成药性和临床应用。共晶技术作为一种常用的晶体工程策略,在改善中药活性成分的理化性质及提升其成药性方面展现出了巨大潜力。综述系统介绍了中药活性成分共晶的开发与应用进展,探讨共晶在改善中药活性成分成药性方面的潜力及局限性,以期为中药活性成分的共晶技术研究与新药开发提供参考。

     

    Abstract: The active components of traditional Chinese medicine (TCM) often exhibit low water solubility and poor stability, which results in poor druggability and limited clinical application. As a commonly used crystal engineering strategy, co-crystallization shows great potential in improving the physicochemical properties of TCM and enhancing their druggability. This review gives a comprehensive introduction to the development and application of pharmaceutical cocrystals in TCM and explores the potential and limitations of cocrystallization in improving the druggability of TCM active components, aiming to provide useful information for co-crystallization research and drug development of TCM.

     

/

返回文章
返回